Home › NDC Lookup › RxCUI directory › RxCUI 212549

Amlodipine 5 MG Oral Tablet [Norvasc] — RxCUI 212549

RxNorm drug concept · Semantic branded drug
RxCUI 212549 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI212549
Official nameAmlodipine 5 MG Oral Tablet [Norvasc]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNorvasc 5 MG Oral Tablet; Norvasc (as amlodipine besylate) 5 MG Oral Tablet
FDA products mapped6
Package NDCs mapped10
Reported Medicaid activity (SDUD)385 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Amlodipine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It lowers high blood pressure, which reduces your risk of strokes and heart attacks. It also treats certain kinds of angina (chest pain) and coronary artery disease. Your doctor wi...
  • Take it by mouth, usually once a day, exactly as your prescriber directs. If you use Katerzia suspension, shake it first. It works gradually, so your dose may be adjusted over a we...
  • Ankle or foot swelling is the most common, especially at higher doses. Some people feel tired, dizzy, flushed, or sleepy, or notice a pounding heartbeat. Call your doctor if these...
  • Call if your chest pain worsens, you faint, you notice yellow skin or eyes, or you have swelling of the face or throat. Those need prompt attention.
📖 Read our full Amlodipine guide →

🕸️ Concept Web — How Amlodipine 5 MG Oral Tablet [Norvasc] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amlodipine 5 MG Oral Tablet [Norvasc] RxCUI 212549

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Amlodipine 17767
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Norvasc 58927
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amlodipine Oral Tablet 370573
    • Amlodipine Oral Product 1152291
    • Amlodipine Pill 1152292
    • Amlodipine Oral Tablet [Norvasc] 368359
    • Norvasc Oral Product 1185732
    • Norvasc Pill 1185733
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amlodipine 5 MG Oral Tablet SCD · 197361
  • Amlodipine 5 MG SCDC · 329528
  • Amlodipine Oral Tablet SCDF · 370573
  • Amlodipine Oral Product SCDG · 1152291
  • Amlodipine Pill SCDG · 1152292

Brand-Name Concepts

  • Amlodipine 5 MG [Norvasc] SBDC · 572722
  • Amlodipine Oral Tablet [Norvasc] SBDF · 368359
  • Norvasc Oral Product SBDG · 1185732
  • Norvasc Pill SBDG · 1185733
  • Norvasc BN · 58927

📦 FDA Products & Package NDCs

6 products · 10 package NDCs
10 package NDCs map to RxCUI 212549 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00069-1520-68 90 TABLET in 1 BOTTLE (0069-1520-68) Norvasc PFIZER LABORATORIES DIV PFIZER INC 1992-07-31
00069-1530-68 90 TABLET in 1 BOTTLE (0069-1530-68) Norvasc PFIZER LABORATORIES DIV PFIZER INC 1992-07-31
00069-1530-72 300 TABLET in 1 BOTTLE (0069-1530-72) Norvasc PFIZER LABORATORIES DIV PFIZER INC 1992-07-31
00069-1540-68 90 TABLET in 1 BOTTLE (0069-1540-68) Norvasc PFIZER LABORATORIES DIV PFIZER INC 1992-07-31
58151-0353-77 90 TABLET in 1 BOTTLE (58151-353-77) Norvasc Viatris Specialty LLC 2024-11-12
58151-0354-30 300 TABLET in 1 BOTTLE (58151-354-30) Norvasc Viatris Specialty LLC 2025-01-23
58151-0354-77 90 TABLET in 1 BOTTLE (58151-354-77) Norvasc Viatris Specialty LLC 2024-12-31
58151-0354-88 100 BLISTER PACK in 1 BOX, UNIT-DOSE (58151-354-88) / 1 TAB... Norvasc Viatris Specialty LLC 2024-09-24
58151-0355-77 90 TABLET in 1 BOTTLE (58151-355-77) Norvasc Viatris Specialty LLC 2024-05-24
58151-0355-88 100 BLISTER PACK in 1 BOX, UNIT-DOSE (58151-355-88) / 1 TAB... Norvasc Viatris Specialty LLC 2024-02-09
Observed labelers: Viatris Specialty LLC (6) · PFIZER LABORATORIES DIV PFIZER INC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.